Granzyme B inhibition reduces disease severity in autoimmune blistering diseases
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Granzyme B inhibition reduces disease severity in autoimmune blistering diseases ; volume:12 ; number:1 ; day:12 ; month:1 ; year:2021 ; pages:1-14 ; date:12.2021
Nature Communications ; 12, Heft 1 (12.1.2021), 1-14, 12.2021
- Urheber
-
Hiroyasu, Sho
Zeglinski, Matthew R.
Zhao, Hongyan
Pawluk, Megan A.
Turner, Christopher T.
Kasprick, Anika
Tateishi, Chiharu
Nishie, Wataru
Burleigh, Angela
Lennox, Peter A.
Van Laeken, Nancy
Carr, Nick J.
Petersen, Frank
Crawford, Richard I.
Shimizu, Hiroshi
Tsuruta, Daisuke
Ludwig, Ralf
Granville, David J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-020-20604-3
- URN
-
urn:nbn:de:101:1-2021020718525491110102
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hiroyasu, Sho
- Zeglinski, Matthew R.
- Zhao, Hongyan
- Pawluk, Megan A.
- Turner, Christopher T.
- Kasprick, Anika
- Tateishi, Chiharu
- Nishie, Wataru
- Burleigh, Angela
- Lennox, Peter A.
- Van Laeken, Nancy
- Carr, Nick J.
- Petersen, Frank
- Crawford, Richard I.
- Shimizu, Hiroshi
- Tsuruta, Daisuke
- Ludwig, Ralf
- Granville, David J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms
Bruton’s tyrosine kinase inhibition reduces disease severity in a model of secondary progressive autoimmune demyelination
Anti-Axl antibody treatment reduces the severity of experimental autoimmune encephalomyelitis
Autoimmune Diseases
Hyposalivation in autoimmune diseases
Therapy of autoimmune diseases
Symposium 5 - Autoimmune Diseases
Autoimmune diseases, including allergy
Autoimmune Diseases and Complement Genes
Combination treatment in autoimmune diseases
Bridging autoinflammatory and autoimmune diseases
Systems genetics in polygenic autoimmune diseases
Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms
Bruton’s tyrosine kinase inhibition reduces disease severity in a model of secondary progressive autoimmune demyelination
Anti-Axl antibody treatment reduces the severity of experimental autoimmune encephalomyelitis
Autoimmune Diseases
Hyposalivation in autoimmune diseases
Therapy of autoimmune diseases
Symposium 5 - Autoimmune Diseases
Autoimmune diseases, including allergy
Autoimmune Diseases and Complement Genes
Combination treatment in autoimmune diseases
Bridging autoinflammatory and autoimmune diseases
Systems genetics in polygenic autoimmune diseases
Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms
Bruton’s tyrosine kinase inhibition reduces disease severity in a model of secondary progressive autoimmune demyelination
Anti-Axl antibody treatment reduces the severity of experimental autoimmune encephalomyelitis
Autoimmune Diseases
Hyposalivation in autoimmune diseases
Therapy of autoimmune diseases
Symposium 5 - Autoimmune Diseases
Autoimmune diseases, including allergy
Autoimmune Diseases and Complement Genes
Combination treatment in autoimmune diseases
Bridging autoinflammatory and autoimmune diseases